- Home
- PHVS vs GRC Comparison
PHVS vs GRC Comparison
Compare PHVS & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- GRC
- Stock Information
- Founded
- PHVS 2015
- GRC 1933
- Country
- PHVS Netherlands
- GRC United States
- Employees
- PHVS N/A
- GRC N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- GRC Fluid Controls
- Sector
- PHVS Health Care
- GRC Industrials
- Exchange
- PHVS Nasdaq
- GRC Nasdaq
- Market Cap
- PHVS 1.0B
- GRC 1.0B
- IPO Year
- PHVS 2021
- GRC N/A
- Fundamental
- Price
- PHVS $17.11
- GRC $37.79
- Analyst Decision
- PHVS Strong Buy
- GRC
- Analyst Count
- PHVS 5
- GRC 0
- Target Price
- PHVS $41.60
- GRC N/A
- AVG Volume (30 Days)
- PHVS 49.2K
- GRC 63.8K
- Earning Date
- PHVS 11-13-2024
- GRC 02-07-2025
- Dividend Yield
- PHVS N/A
- GRC 1.95%
- EPS Growth
- PHVS N/A
- GRC 33.88
- EPS
- PHVS N/A
- GRC 1.45
- Revenue
- PHVS N/A
- GRC $657,528,000.00
- Revenue This Year
- PHVS N/A
- GRC $1.05
- Revenue Next Year
- PHVS N/A
- GRC $3.60
- P/E Ratio
- PHVS N/A
- GRC $26.09
- Revenue Growth
- PHVS N/A
- GRC 1.95
- 52 Week Low
- PHVS $15.21
- GRC $30.47
- 52 Week High
- PHVS $33.00
- GRC $43.79
- Technical
- Relative Strength Index (RSI)
- PHVS 38.75
- GRC 45.34
- Support Level
- PHVS $17.11
- GRC $37.24
- Resistance Level
- PHVS $18.70
- GRC $39.62
- Average True Range (ATR)
- PHVS 1.10
- GRC 0.86
- MACD
- PHVS -0.07
- GRC 0.19
- Stochastic Oscillator
- PHVS 34.65
- GRC 36.63
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.